However, our results indicate that the deletion of CXCR3 resulted in enhanced antigen-specific CD4+ T cell responses to rIAV immunization in the lungs, suggesting that the presence of CXCR3 signalling is not wholly beneficial in the context of mucosal TB vaccination. The gene discussed is CXCR3; the disease is tuberculosis.